ERBB2 and pancreatic neoplasm: CD137 expression on the surface of NK cells with FcR-VV or -VF, which conjugates readily with IgG-Fc, was increased to enhance NK cell cytotoxicity in association with Tmab administration, resulting in improved ADCC against the HER2-low-expressing pancreatic cancer cell line.